| Pharmacokinetics in patients with cystic fibrosis: a systematic review of data published between 1999 and 2019 PJ De Sutter, E Gasthuys, E Van Braeckel, P Schelstraete, S Van Biervliet, ... Clinical pharmacokinetics 59, 1551-1573, 2020 | 21 | 2020 |
| High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium A De Bleeckere, S Van den Bossche, PJ De Sutter, T Beirens, A Crabbé, ... Biofilm 5, 100106, 2023 | 6 | 2023 |
| Predictive performance of physiologically based pharmacokinetic modelling of beta-lactam antibiotic concentrations in adipose, bone, and muscle tissues PJ De Sutter, P De Cock, TN Johnson, H Musther, E Gasthuys, ... Drug Metabolism and Disposition 51 (4), 499-508, 2023 | 4 | 2023 |
| Altered intravenous drug disposition in people living with cystic fibrosis: A meta‐analysis integrating top‐down and bottom‐up data PJ De Sutter, M Van Haeverbeke, E Van Braeckel, S Van Biervliet, ... CPT: Pharmacometrics & Systems Pharmacology 11 (8), 951-966, 2022 | 3 | 2022 |
| Comment on:“Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update” PJ De Sutter, J De Waele, A Vermeulen Clinical Pharmacokinetics, 1-2, 2021 | 1 | 2021 |
